Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Povidien was an Irish healthcare company established in 2020 to address the urgent need for effective antiseptic solutions during the COVID-19 pandemic. The company focused on developing and distributing ready-to-use povidone-iodine formulations, including nasal and throat sprays, designed to reduce the transmission of viruses between patients and healthcare workers. Povidien collaborated with academic researchers and NHS-affiliated manufacturers to ensure the safety and efficacy of its products, specifically targeting dental and hospital settings. Despite its initial success in providing low-cost interventions, the company was dissolved in early 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Povidien.